Author:
Jia Ang,Jiang Hongfei,Liu Wenjing,Chen Pengwei,Xu Qi,Zhang Renshuai,Sun Jufeng
Reference44 articles.
1. Supriyo Chakraborty. A review on coronary artery disease, its risk factors, and therapeutics;Malakar;J. Cell. Physiol.,2019
2. Gv Chanukya. Rosuvastatin and fenofibrate combination in the treatment of mixed hyperlipidemia: a narrative review;Biswas;J. Curr. Med. Res. Opin.,2021
3. Three musketeers for lowering cholesterol: statins, ezetimibe and evolocumab;Xu;Curr. Med. Chem.,2021
4. Development of triglyceride-lowering drugs to address residual cardiovascular risk: strategic and clinical considerations;Hallén;Eur. Heart J. Cardiavasc. Pharmacother.,2018
5. Lipid-lowering therapies for atherosclerosis: statins, fibrates, ezetimibe and pcsk9 monoclonal antibodies;Ali;Curr. Med. Chem.,2021